Ardsley Advisory Partners »

Mirum Pharmaceuticals shares owned by Ardsley Advisory Partners

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Ardsley Advisory Partners from 13F filings

Historical chart of Ardsley Advisory Partners investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Ardsley Advisory Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Ardsley Advisory Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.2M 100k 31.60

More positions owned by Ardsley Advisory Partners

Celestica Sub Vtg Shs (CLS)
Bioceres Crop Solutions Corp SHS (BIOX)
Aspen Aerogels (ASPN)
Sunopta (STKL)
Itron (ITRI)
Nortonlifelock (GEN)
Sunrun Call Option (RUN)
Pacira Pharmaceuticals Call Option (PCRX)
Procore Technologies (PCOR)
First Solar (FSLR)
Ftai Aviation SHS (FTAI)
Vistra Energy (VST)
Flex Ord (FLEX)
Amazon (AMZN)
Sentinelone Cl A (S)

View all positions for Ardsley Advisory Partners

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals